Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 ...

Ahead of this year's Floretina meeting and International Congress on OCT Angiography, En Face OCT and Advances in OCT (ICOOR), David Hutton of Ophthalmology Times spoke with Charles Wykoff, MD, PhD.

"To our knowledge, this is the first study to evaluate diabetic retinopathy progression using data generated from clinical ...

They included adults with type 2 diabetes initiating study drugs without prior diagnosis or treatment for proliferative diabetic retinopathy or other advanced retinal diseases. For the incident ...